ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Combined dapagliflozin and pioglitazone therapy in diabetic nephropathy: no added benefit beyond monotherapy in inflammation and fibrosis.
Cinakova A et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.